Catiz
Catiz is a tyrosine kinase inhibitor used for the treatment of patients with locally advanced HER2+ metastatic breast cancer in combination with Trastuzumab and capecitabine.
Therapeutic Area
Oncology
Active Ingredient
Tucatinib
Line
Oncology
Dosage forms
50 mg x 60 tablets
150 mg x 60 tablets
150 mg x 120 tablets
